Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Does Atelectasis Cause Fever After Surgery? Putting a Damper on Dogma.

Crompton JG, Crompton PD, Matzinger P.

JAMA Surg. 2019 May 1;154(5):375-376. doi: 10.1001/jamasurg.2018.5645. No abstract available.

PMID:
30840058
2.

Does the Danger model shed any light on central tolerance?: A response to Al-Yassin.

Fuchs EJ, Matzinger P.

Scand J Immunol. 2018 Sep;88(3):e12660. doi: 10.1111/sji.12660. Epub 2018 Apr 19. No abstract available.

3.

Mechanisms by which Porphyromonas gingivalis evades innate immunity.

Abdi K, Chen T, Klein BA, Tai AK, Coursen J, Liu X, Skinner J, Periasamy S, Choi Y, Kessler BM, Palmer RJ, Gittis A, Matzinger P, Duncan MJ, Singh NJ.

PLoS One. 2017 Aug 3;12(8):e0182164. doi: 10.1371/journal.pone.0182164. eCollection 2017.

4.

Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis.

Möhle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, Alutis M, French T, Hambardzumyan D, Matzinger P, Dunay IR, Wolf SA.

Cell Rep. 2016 May 31;15(9):1945-56. doi: 10.1016/j.celrep.2016.04.074. Epub 2016 May 19.

5.

Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks.

Morgun A, Dzutsev A, Dong X, Greer RL, Sexton DJ, Ravel J, Schuster M, Hsiao W, Matzinger P, Shulzhenko N.

Gut. 2015 Nov;64(11):1732-43. doi: 10.1136/gutjnl-2014-308820. Epub 2015 Jan 22.

6.

Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularly.

Abdi K, Singh NJ, Spooner E, Kessler BM, Radaev S, Lantz L, Xiao TS, Matzinger P, Sun PD, Ploegh HL.

J Immunol. 2014 Jun 15;192(12):6028-36. doi: 10.4049/jimmunol.1400159. Epub 2014 May 12.

7.

Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer.

Mine KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N, Deng T, Brenna SM, Carvalho CR, Ribalta JC, Bustin M, Matzinger P, Silva ID, Lyng H, Gerbase-DeLima M, Morgun A.

Nat Commun. 2013;4:1806. doi: 10.1038/ncomms2693.

8.

The evolution of the danger theory. Interview by Lauren Constable, Commissioning Editor.

Matzinger P.

Expert Rev Clin Immunol. 2012 May;8(4):311-7. doi: 10.1586/eci.12.21.

9.

Lipopolysaccharide-activated dendritic cells: "exhausted" or alert and waiting?

Abdi K, Singh NJ, Matzinger P.

J Immunol. 2012 Jun 15;188(12):5981-9. doi: 10.4049/jimmunol.1102868. Epub 2012 May 4.

10.

Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut.

Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, Orandle M, Mayer L, Macpherson AJ, McCoy KD, Fraser-Liggett C, Matzinger P.

Nat Med. 2011 Nov 20;17(12):1585-93. doi: 10.1038/nm.2505.

11.

Resident peritoneal NK cells.

Gonzaga R, Matzinger P, Perez-Diez A.

J Immunol. 2011 Dec 15;187(12):6235-42. doi: 10.4049/jimmunol.1101540. Epub 2011 Nov 11.

12.

Tissue-based class control: the other side of tolerance.

Matzinger P, Kamala T.

Nat Rev Immunol. 2011 Mar;11(3):221-30. doi: 10.1038/nri2940. Review.

PMID:
21350581
13.

Spontaneous mutation in the Cd79b gene leads to a block in B-lymphocyte development at the C' (early pre-B) stage.

Shulzhenko N, Morgun A, Matzinger P.

Genes Immun. 2009 Dec;10(8):722-6. doi: 10.1038/gene.2009.70. Epub 2009 Sep 3.

14.

An immunologist's view on specific immunotherapy.

Matzinger P.

Drugs Today (Barc). 2008 Dec;44 Suppl B:51-4. No abstract available.

PMID:
19221620
15.

Unexpected regeneration in middle-aged mice.

Reines B, Cheng LI, Matzinger P.

Rejuvenation Res. 2009 Feb;12(1):45-52. doi: 10.1089/rej.2008.0792.

16.

Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.

Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL.

Nat Immunol. 2009 Feb;10(2):149-57. doi: 10.1038/ni.1695. Epub 2009 Jan 11.

17.

Antigen-specific T-T interactions regulate CD4 T-cell expansion.

Helft J, Jacquet A, Joncker NT, Grandjean I, Dorothée G, Kissenpfennig A, Malissen B, Matzinger P, Lantz O.

Blood. 2008 Aug 15;112(4):1249-58. doi: 10.1182/blood-2007-09-114389. Epub 2008 Jun 6.

18.

The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis.

Usharauli D, Perez-Diez A, Matzinger P.

Nat Protoc. 2006;1(2):672-82.

PMID:
17406295
19.

CD4 cells can be more efficient at tumor rejection than CD8 cells.

Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P.

Blood. 2007 Jun 15;109(12):5346-54. Epub 2007 Feb 27.

20.

Friendly and dangerous signals: is the tissue in control?

Matzinger P.

Nat Immunol. 2007 Jan;8(1):11-3.

PMID:
17179963
21.

Crystal-ball gazing--the future of immunological research viewed from the cutting edge.

Brent L, Cohen IR, Doherty PC, Feldmann M, Matzinger P, Ghost Lab, Holgate ST, Lachmann P, Mitchison NA, Nossal G, Rose NR, Zinkernagel R.

Clin Exp Immunol. 2007 Jan;147(1):1-10. No abstract available.

22.

T-cell control of IL-12p75 production.

Abdi K, Singh N, Matzinger P.

Scand J Immunol. 2006 Aug;64(2):83-92.

23.

Molecular profiling improves diagnoses of rejection and infection in transplanted organs.

Morgun A, Shulzhenko N, Perez-Diez A, Diniz RV, Sanson GF, Almeida DR, Matzinger P, Gerbase-DeLima M.

Circ Res. 2006 Jun 23;98(12):e74-83.

PMID:
16794196
24.

Thymic cortical epithelium induces self tolerance.

Goldman KP, Park CS, Kim M, Matzinger P, Anderson CC.

Eur J Immunol. 2005 Mar;35(3):709-17.

25.

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Seong SY, Matzinger P.

Nat Rev Immunol. 2004 Jun;4(6):469-78. No abstract available.

PMID:
15173835
26.

'Educated' dendritic cells act as messengers from memory to naive T helper cells.

Alpan O, Bachelder E, Isil E, Arnheiter H, Matzinger P.

Nat Immunol. 2004 Jun;5(6):615-22. Epub 2004 May 23.

PMID:
15156140
27.

Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells?

Grandjean I, Duban L, Bonney EA, Corcuff E, Di Santo JP, Matzinger P, Lantz O.

J Exp Med. 2003 Oct 6;198(7):1089-102. Epub 2003 Sep 29.

28.

Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway.

Valujskikh A, Lantz O, Celli S, Matzinger P, Heeger PS.

Nat Immunol. 2002 Sep;3(9):844-51. Epub 2002 Aug 12.

PMID:
12172545
29.

Immune response to engineered tissues and cells: breakout session summary.

Harlan DM, Metzger DW, Karp CL, Matzinger P, Munn DH, Ransohoff RM.

Ann N Y Acad Sci. 2002 Jun;961:350-1. No abstract available.

PMID:
12081937
30.

An innate sense of danger.

Matzinger P.

Ann N Y Acad Sci. 2002 Jun;961:341-2. Review. No abstract available.

PMID:
12081934
31.

Immunological concerns with bioengineering approaches.

Harlan DM, Karp CL, Matzinger P, Munn DH, Ransohoff RM, Metzger DW.

Ann N Y Acad Sci. 2002 Jun;961:323-30. Review. No abstract available.

PMID:
12081930
32.

The danger model: a renewed sense of self.

Matzinger P.

Science. 2002 Apr 12;296(5566):301-5.

PMID:
11951032
33.

Intensity of the vaccine-elicited immune response determines tumor clearance.

Perez-Diez A, Spiess PJ, Restifo NP, Matzinger P, Marincola FM.

J Immunol. 2002 Jan 1;168(1):338-47.

34.

Essay 1: the Danger model in its historical context.

Matzinger P.

Scand J Immunol. 2001 Jul-Aug;54(1-2):4-9. Review. No abstract available.

35.

Introduction to the series. Danger model of immunity.

Matzinger P.

Scand J Immunol. 2001 Jul-Aug;54(1-2):2-3. No abstract available.

36.

The role of dendritic cells, B cells, and M cells in gut-oriented immune responses.

Alpan O, Rudomen G, Matzinger P.

J Immunol. 2001 Apr 15;166(8):4843-52.

37.

Liver transplants induce deletion of liver-specific T cells.

Celli S, Matzinger P.

Transplant Proc. 2001 Feb-Mar;33(1-2):102-3. No abstract available.

PMID:
11266728
38.

Gamma chain required for naïve CD4+ T cell survival but not for antigen proliferation.

Lantz O, Grandjean I, Matzinger P, Di Santo JP.

Nat Immunol. 2000 Jul;1(1):54-8.

PMID:
10881175
39.

Testing time-, ignorance-, and danger-based models of tolerance.

Anderson CC, Carroll JM, Gallucci S, Ridge JP, Cheever AW, Matzinger P.

J Immunol. 2001 Mar 15;166(6):3663-71.

40.

Danger signals: SOS to the immune system.

Gallucci S, Matzinger P.

Curr Opin Immunol. 2001 Feb;13(1):114-9. Review.

PMID:
11154927
41.

Immunity or tolerance: opposite outcomes of microchimerism from skin grafts.

Anderson CC, Matzinger P.

Nat Med. 2001 Jan;7(1):80-7.

PMID:
11135620
42.

Danger: the view from the bottom of the cliff.

Anderson CC, Matzinger P.

Semin Immunol. 2000 Jun;12(3):231-8; discussion 257-344. No abstract available.

PMID:
10910744
43.

Natural adjuvants: endogenous activators of dendritic cells.

Gallucci S, Lolkema M, Matzinger P.

Nat Med. 1999 Nov;5(11):1249-55.

PMID:
10545990
44.

Use of transgenic cell lines in mechanistic studies of drug metabolism.

Gasser R, Funk C, Matzinger P, Klemisch W, Viger-Chougnet A.

Toxicol In Vitro. 1999 Aug-Oct;13(4-5):625-32.

PMID:
20654526
45.

On the lifespan of virgin T lymphocytes.

Di Rosa F, Ramaswamy S, Ridge JP, Matzinger P.

J Immunol. 1999 Aug 1;163(3):1253-7.

46.

Graft tolerance: a duel of two signals.

Matzinger P.

Nat Med. 1999 Jun;5(6):616-7. No abstract available.

PMID:
10371494
47.

Determination of the structure of seleno-methionine-labelled hydroxymethylbilane synthase in its active form by multi-wavelength anomalous dispersion.

Hädener A, Matzinger PK, Battersby AR, McSweeney S, Thompson AW, Hammersley AP, Harrop SJ, Cassetta A, Deacon A, Hunter WN, Nieh YP, Raftery J, Hunter N, Helliwell JR.

Acta Crystallogr D Biol Crystallogr. 1999 Mar;55(Pt 3):631-43.

PMID:
10089459
48.

An innate sense of danger.

Matzinger P.

Semin Immunol. 1998 Oct;10(5):399-415. Review. No abstract available.

PMID:
9840976
49.

Much IDO about pregnancy.

Bonney EA, Matzinger P.

Nat Med. 1998 Oct;4(10):1128-9. No abstract available.

PMID:
9771744
50.

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

Ridge JP, Di Rosa F, Matzinger P.

Nature. 1998 Jun 4;393(6684):474-8.

PMID:
9624003

Supplemental Content

Loading ...
Support Center